Journal profile · GENETICS & HEREDITY
Epigenomes
ISSN 2075-4655 · MDPI AG · Switzerland
Epigenomes: CAS Zone 4 · Biology (2025 upgraded edition); impact factor 4.1 (journal website); JCR Q2 (journal website); fully open access; APC charged, amount not published; median 52 days to acceptance (103 articles, last 24 months); 53 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Epigenomes is published by MDPI AG and is in Zone 4 of Biology in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Epigenetics and DNA Methylation, RNA modifications and cancer and Genomics and Chromatin Dynamics, together about 46.2% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
AimsEpigenomes (ISSN 2075-4655) is an open access journal which provides an advanced forum for research studies on Epigenetics and Epigenomics. It publishes primarily original research papers, short communications and reviews. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the maximum length of the papers. The full experimental details must be provided so that the results can be reproduced. We also encourage the publication of timely reviews and of commentaries on hot topics of interest to the Epigenomics community.ScopeEpigenetics, defined as the study of the information carried by the genome that is not encoded by DNA, as well as Epitranscriptomics, defined as the sum of the functionally relevant changes to the transcriptome that do not involve a direct change in the RNA sequence, are two of the most rapidly expanding fields, with clear therapeutic implications.The scope of Epigenomes includes, but is not limited to the following subjects: Functional studies dealing with identification/modus operandi/structure–function relationships or biological activity of methylases, demethylases, acetylases, methyl-binding proteins, or any other type of enzymes involved in DNA, RNA or histone modifications; Studies reporting genome-wide epigenetic status of cells or tissues in specific biologically relevant contexts; Studies describing insights into the role of epigenetics and epitranscriptomics in physical diseases (e.g., cancer, premature aging, allergy, obesity) and psychopathologies (e.g., schizophrenia, autism, addiction); Studies describing the effect of environmental changes on the epigenetic or epitranscriptomic status of cells or tissues; Studies describing the inheritance or fixation of epigenetic characteristics; Description of novel methods to study DNA methylation, histone methylation, RNA modifications, histone acetylation or other types of epigenetic and/or epitranscriptomic modifications in a global fashion; Studies describing novel tools and technologies for epigenetic or epitranscriptomic studies and therapeutics. MDPI Publication Ethics Statement MDPI is a member of the Committee on Publication Ethics (COPE). MDPI takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data fa
From the journal's Aims & Scope
Research area (LetPub): GENETICS & HEREDITY
Editorial board by country: none in mainland China; most named United States 10, Australia 4, Italy 3, Canada 3, United Kingdom 2 (31 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology30.2%
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology9.4%
- Genomics and Chromatin DynamicsBiochemistry, Genetics and Molecular Biology6.6%
- Cancer-related gene regulationBiochemistry, Genetics and Molecular Biology6.1%
- Plant Molecular Biology ResearchAgricultural and Biological Sciences5.1%
- Histone Deacetylase Inhibitors ResearchBiochemistry, Genetics and Molecular Biology5.1%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology3.4%
- Genetics and Neurodevelopmental DisordersBiochemistry, Genetics and Molecular Biology3.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Biology Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 4 |
| Minor | Genetics & Heredity | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Biology Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Biology | Zone 3 |
| Minor | Genetics & Heredity | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · Genetics and Heredity
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCPubMedEmbaseCASPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 4.1Publisher website ·
- 5-year impact factor (publisher) 2025
- 3.5Publisher website ·
- CiteScore 2026-06
- 5.3LetPub ·
- CiteScore (publisher)
- 5.3Publisher website ·
- SJR 2026-06
- 1.19LetPub ·
- SNIP 2026-06
- 0.74LetPub ·
- h-index
- 30OpenAlex ·
- i10-index
- 131OpenAlex ·
- 2-year mean citedness
- 4.44OpenAlex ·
- Self-citation rate
- 2.4%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 53LetPub ·
Articles by year OpenAlex count · 357 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 58 | 58 | 21 |
| 2025 | 53 | 53 | 245 |
| 2024 | 45 | 45 | 427 |
| 2023 | 33 | 33 | 411 |
| 2022 | 43 | 43 | 664 |
| 2021 | 29 | 29 | 453 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
52 daysMedian, submission to acceptance · P25–P75 38 days – 65 days
- Acceptance to online
- median 4 days (103 articles)
- Submission to online
- median 57 days
- Sample
- 103 articles with submission and acceptance dates (122 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 11 weeksLetPub ·
- Submission to first decision
- 19.8 daysPublisher website ·
- Acceptance to publication
- 4.6 daysPublisher website ·
- Submission to publication (journal-reported)
- about 6 weeksDOAJ ·
- Peer review
- Open peer review, Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | CHF 1,500 | Yes | CC BY | |
| OpenAlex | CHF 1,500 | — | — | |
| LetPub | CHF 1,500 | Yes | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 250 words
- Reference style
- Author–date
- Templates
- LaTeX and Word
- Suggested reviewers
- Required, 3
- Graphical abstract
- Optional
- Cover letter
- Required
Article types accepted20
- articleArticle: These are original research manuscripts. The work should report scientifically sound experiments and provide a substantial amount of new information.Length not stated
- book reviewAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- brief communicationAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- brief reportAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- case reportAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- commentaryAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- conference reportAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- editorialAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- hypothesisAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- letterAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- opinionAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- perspectiveAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- protocolAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- registered reportAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- reviewAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- scoping reviewA Scoping Review type can be submitted as a Review. The structure is similar to that of a review.Length not stated
- systematic reviewAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- technical noteAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- tutorialAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
- viewpointAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Preprints
- Authorship Authorship
MDPI follows the International Committee of Medical Journal Editors (ICMJE) guidelines which state that, in order to qualify for authorship of a manuscript, the following criteria should be observed: Make substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data for the work; Draft the work or review it critically for important intel…
Source ↗Publisher website ·- Conflicts of interest Conflicts of Interest
Citation policy: cite sources clearly, obtain permission where appropriate, avoid excessive self-citation, do not copy unread references, do not preferentially cite own or friends' publications, do not cite advertisements. Model summary
According to The International Committee of Medical Journal Editors, “Authors should avoid entering into agreements with study sponsors, both for-profit and non-profit, that interfere with authors’ access to all of the study’s data or that interfere with their ability to analyze and interpret the data and to prepare and publish manuscripts independently when and where they choose.” All authors mus…
Source ↗Publisher website ·- Data availability Data availability statements
Data availability statements are required for all articles published with MDPI. Model summary
Data availability statements are required for all articles published with MDPI. During the peer review and editorial decision process, authors can be asked to share existing datasets or raw data that have been analyzed in the manuscript, and whether they will be made available to other researchers following publication. Authors will also be asked for the details of any existing datasets that have …
Source ↗Publisher website ·- Publication ethics Publication Ethics Statement
Epigenomes is a member of the Committee on Publication Ethics (COPE). We fully adhere to its Code of Conduct and to its Best Practice Guidelines. The editors of this journal enforce a rigorous peer review process together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsific…
Source ↗Publisher website ·- License & copyright Copyright / Open Access
Articles published in Epigenomes will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution License (CC BY). The copyright is retained by the author(s). MDPI will insert the following note at the end of the published text: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and…
Source ↗Publisher website ·- Open access Open access publication fees
If you transfer your manuscript to another open access (OA) journal, you will be charged an Article Processing Charge (APC) if your article is accepted for publication. The APC for each journal can be found on the individual journal’s website. For more information about APCs, please see here.
Source ↗Publisher website ·- Peer review Editorial Process and Peer Review
All submissions are thoroughly peer-reviewed by experts within the field and undergo a structured editorial workflow designed to ensure quality, transparency, and scientific integrity. The full editorial procedure is available on the Editorial Process page and is also provided below. Pre-check Pre-check consists of a technical pre-check performed by the Editorial Office and an editorial pre-check …
Source ↗Publisher website ·- Preprints Preprints and Conference Papers
Epigenomes accepts submissions that have previously been made available as preprints provided that they have not undergone peer review. A preprint is a draft version of a paper made available online before submission to a journal. MDPI operates Preprints, a preprint server to which submitted papers can be uploaded directly after completing journal submission. Note that Preprints operates independe…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- MDPI AG
- Country or region
- Switzerland
- Language
- English
- ISSN
- 2075-4655
- Latest issue on the website
- Volume 10 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Epigenomes
What CAS zone is Epigenomes in?
In the 2025 upgraded edition of the CAS Journal Ranking, Epigenomes is in Zone 4 of Biology, and in Zone 4 of the minor category Genetics & Heredity. In the 2026 Xinrui edition it is in Zone 3 of Biology. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Epigenomes?
The journal's website gives an impact factor of 4.1 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 5.3, h-index 30.
How long does peer review take at Epigenomes?
Based on the dates recorded on 103 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 52 days (interquartile range 38–65 days); authors report an average review time of about 11 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Epigenomes in?
The journal's website gives JCR Q2; by category, Genetics and Heredity Q2. JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Biology.
What are the manuscript requirements of Epigenomes?
According to the journal's author guidelines: Abstract: ≤ 250 words; Reference style: Author–date; Templates: LaTeX and Word; Suggested reviewers: Required, 3; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Epigenomes based?
Of the 31 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (10), Australia (4) and Italy (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Epigenomes?
According to LetPub and DOAJ records, Epigenomes is indexed in ESCI, Scopus and DOAJ. The journal's website also lists Web of Science, PMC, PubMed, Embase and CAS; that list has not been checked against each database.
Is Epigenomes open access, and what is the APC?
Epigenomes is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .